The global Nanopharmaceutical Drugs market is projected to grow from US$ 33930 million in 2024 to US$ 54830 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period.

Nanopharmaceutical Drugs Market

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.

There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Nanopharmaceutical Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Nanopharmaceutical Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nanopharmaceutical Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nanopharmaceutical Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Nanopharmaceutical Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Nanopharmaceutical Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Nanopharmaceutical Drugs Market Report

Report Metric	Details
Report Name	Nanopharmaceutical Drugs Market
Accounted market size in 2024	US$ 33930 million
Forecasted market size in 2030	US$ 54830 million
CAGR	8.3
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Liposomes Polymer Nanocrystals Protein Others
Segment by Application	Oncology Neurology Immunology Anti-Infective Cardiovascular Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Gilead Sciences, Abbvie, Amgen, Roche, Novartis, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Nanopharmaceutical Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Nanopharmaceutical Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanopharmaceutical Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Nanopharmaceutical Drugs Market growing?

Ans: The Nanopharmaceutical Drugs Market witnessing a CAGR of 8.3 during the forecast period 2025-2030.

What is the Nanopharmaceutical Drugs Market size in 2030?

Ans: The Nanopharmaceutical Drugs Market size in 2030 will be US$ 54830 million.

Who are the main players in the Nanopharmaceutical Drugs Market report?

Ans: The main players in the Nanopharmaceutical Drugs Market are AstraZeneca, Gilead Sciences, Abbvie, Amgen, Roche, Novartis, Sanofi

What are the Application segmentation covered in the Nanopharmaceutical Drugs Market report?

Ans: The Applications covered in the Nanopharmaceutical Drugs Market report are Oncology, Neurology, Immunology, Anti-Infective, Cardiovascular, Others

What are the Type segmentation covered in the Nanopharmaceutical Drugs Market report?

Ans: The Types covered in the Nanopharmaceutical Drugs Market report are Liposomes, Polymer, Nanocrystals, Protein, Others

1 Study Coverage

1.1 Nanopharmaceutical Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Nanopharmaceutical Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Liposomes

1.2.3 Polymer

1.2.4 Nanocrystals

1.2.5 Protein

1.2.6 Others

1.3 Market by Application

1.3.1 Global Nanopharmaceutical Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Oncology

1.3.3 Neurology

1.3.4 Immunology

1.3.5 Anti-Infective

1.3.6 Cardiovascular

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Nanopharmaceutical Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Nanopharmaceutical Drugs Revenue by Region

2.2.1 Global Nanopharmaceutical Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Nanopharmaceutical Drugs Revenue by Region (2019-2024)

2.2.3 Global Nanopharmaceutical Drugs Revenue by Region (2025-2030)

2.2.4 Global Nanopharmaceutical Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Nanopharmaceutical Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Nanopharmaceutical Drugs Sales by Region

2.4.1 Global Nanopharmaceutical Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Nanopharmaceutical Drugs Sales by Region (2019-2024)

2.4.3 Global Nanopharmaceutical Drugs Sales by Region (2025-2030)

2.4.4 Global Nanopharmaceutical Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Nanopharmaceutical Drugs Sales by Manufacturers

3.1.1 Global Nanopharmaceutical Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Nanopharmaceutical Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nanopharmaceutical Drugs in 2023

3.2 Global Nanopharmaceutical Drugs Revenue by Manufacturers

3.2.1 Global Nanopharmaceutical Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Nanopharmaceutical Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Nanopharmaceutical Drugs Revenue in 2023

3.3 Global Key Players of Nanopharmaceutical Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Nanopharmaceutical Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Nanopharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Nanopharmaceutical Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Nanopharmaceutical Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Nanopharmaceutical Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Nanopharmaceutical Drugs Sales by Type

4.1.1 Global Nanopharmaceutical Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Nanopharmaceutical Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Nanopharmaceutical Drugs Sales Market Share by Type (2019-2030)

4.2 Global Nanopharmaceutical Drugs Revenue by Type

4.2.1 Global Nanopharmaceutical Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Nanopharmaceutical Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Nanopharmaceutical Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Nanopharmaceutical Drugs Price by Type

4.3.1 Global Nanopharmaceutical Drugs Price by Type (2019-2024)

4.3.2 Global Nanopharmaceutical Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Nanopharmaceutical Drugs Sales by Application

5.1.1 Global Nanopharmaceutical Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Nanopharmaceutical Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Nanopharmaceutical Drugs Sales Market Share by Application (2019-2030)

5.2 Global Nanopharmaceutical Drugs Revenue by Application

5.2.1 Global Nanopharmaceutical Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Nanopharmaceutical Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Nanopharmaceutical Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Nanopharmaceutical Drugs Price by Application

5.3.1 Global Nanopharmaceutical Drugs Price by Application (2019-2024)

5.3.2 Global Nanopharmaceutical Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Nanopharmaceutical Drugs Market Size by Type

6.1.1 US & Canada Nanopharmaceutical Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Nanopharmaceutical Drugs Revenue by Type (2019-2030)

6.2 US & Canada Nanopharmaceutical Drugs Market Size by Application

6.2.1 US & Canada Nanopharmaceutical Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Nanopharmaceutical Drugs Revenue by Application (2019-2030)

6.3 US & Canada Nanopharmaceutical Drugs Market Size by Country

6.3.1 US & Canada Nanopharmaceutical Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Nanopharmaceutical Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Nanopharmaceutical Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Nanopharmaceutical Drugs Market Size by Type

7.1.1 Europe Nanopharmaceutical Drugs Sales by Type (2019-2030)

7.1.2 Europe Nanopharmaceutical Drugs Revenue by Type (2019-2030)

7.2 Europe Nanopharmaceutical Drugs Market Size by Application

7.2.1 Europe Nanopharmaceutical Drugs Sales by Application (2019-2030)

7.2.2 Europe Nanopharmaceutical Drugs Revenue by Application (2019-2030)

7.3 Europe Nanopharmaceutical Drugs Market Size by Country

7.3.1 Europe Nanopharmaceutical Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Nanopharmaceutical Drugs Sales by Country (2019-2030)

7.3.3 Europe Nanopharmaceutical Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Nanopharmaceutical Drugs Market Size

8.1.1 China Nanopharmaceutical Drugs Sales (2019-2030)

8.1.2 China Nanopharmaceutical Drugs Revenue (2019-2030)

8.2 China Nanopharmaceutical Drugs Market Size by Application

8.2.1 China Nanopharmaceutical Drugs Sales by Application (2019-2030)

8.2.2 China Nanopharmaceutical Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Nanopharmaceutical Drugs Market Size by Type

9.1.1 Asia Nanopharmaceutical Drugs Sales by Type (2019-2030)

9.1.2 Asia Nanopharmaceutical Drugs Revenue by Type (2019-2030)

9.2 Asia Nanopharmaceutical Drugs Market Size by Application

9.2.1 Asia Nanopharmaceutical Drugs Sales by Application (2019-2030)

9.2.2 Asia Nanopharmaceutical Drugs Revenue by Application (2019-2030)

9.3 Asia Nanopharmaceutical Drugs Sales by Region

9.3.1 Asia Nanopharmaceutical Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Nanopharmaceutical Drugs Revenue by Region (2019-2030)

9.3.3 Asia Nanopharmaceutical Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Nanopharmaceutical Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Nanopharmaceutical Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Overview

11.1.3 Pfizer Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Pfizer Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Pfizer Recent Developments

11.2 Merck

11.2.1 Merck Company Information

11.2.2 Merck Overview

11.2.3 Merck Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Merck Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merck Recent Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Information

11.3.2 AstraZeneca Overview

11.3.3 AstraZeneca Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 AstraZeneca Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 AstraZeneca Recent Developments

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Information

11.4.2 Gilead Sciences Overview

11.4.3 Gilead Sciences Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Gilead Sciences Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Gilead Sciences Recent Developments

11.5 Abbvie

11.5.1 Abbvie Company Information

11.5.2 Abbvie Overview

11.5.3 Abbvie Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Abbvie Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Abbvie Recent Developments

11.6 Amgen

11.6.1 Amgen Company Information

11.6.2 Amgen Overview

11.6.3 Amgen Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Amgen Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Amgen Recent Developments

11.7 Roche

11.7.1 Roche Company Information

11.7.2 Roche Overview

11.7.3 Roche Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Roche Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Roche Recent Developments

11.8 Novartis

11.8.1 Novartis Company Information

11.8.2 Novartis Overview

11.8.3 Novartis Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Novartis Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Novartis Recent Developments

11.9 Sanofi

11.9.1 Sanofi Company Information

11.9.2 Sanofi Overview

11.9.3 Sanofi Nanopharmaceutical Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Sanofi Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Sanofi Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Nanopharmaceutical Drugs Industry Chain Analysis

12.2 Nanopharmaceutical Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Nanopharmaceutical Drugs Production Mode & Process

12.4 Nanopharmaceutical Drugs Sales and Marketing

12.4.1 Nanopharmaceutical Drugs Sales Channels

12.4.2 Nanopharmaceutical Drugs Distributors

12.5 Nanopharmaceutical Drugs Customers

13 Market Dynamics

13.1 Nanopharmaceutical Drugs Industry Trends

13.2 Nanopharmaceutical Drugs Market Drivers

13.3 Nanopharmaceutical Drugs Market Challenges

13.4 Nanopharmaceutical Drugs Market Restraints

14 Key Findings in The Global Nanopharmaceutical Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Nanopharmaceutical Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Liposomes

Table 3. Major Manufacturers of Polymer

Table 4. Major Manufacturers of Nanocrystals

Table 5. Major Manufacturers of Protein

Table 6. Major Manufacturers of Others

Table 7. Global Nanopharmaceutical Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Nanopharmaceutical Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Nanopharmaceutical Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 10. Global Nanopharmaceutical Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 11. Global Nanopharmaceutical Drugs Revenue Market Share by Region (2019-2024)

Table 12. Global Nanopharmaceutical Drugs Revenue Market Share by Region (2025-2030)

Table 13. Global Nanopharmaceutical Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Nanopharmaceutical Drugs Sales by Region (2019-2024) & (K MT)

Table 15. Global Nanopharmaceutical Drugs Sales by Region (2025-2030) & (K MT)

Table 16. Global Nanopharmaceutical Drugs Sales Market Share by Region (2019-2024)

Table 17. Global Nanopharmaceutical Drugs Sales Market Share by Region (2025-2030)

Table 18. Global Nanopharmaceutical Drugs Sales by Manufacturers (2019-2024) & (K MT)

Table 19. Global Nanopharmaceutical Drugs Sales Share by Manufacturers (2019-2024)

Table 20. Global Nanopharmaceutical Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 21. Global Nanopharmaceutical Drugs Revenue Share by Manufacturers (2019-2024)

Table 22. Global Key Players of Nanopharmaceutical Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 23. Nanopharmaceutical Drugs Price by Manufacturers 2019-2024 (USD/MT)

Table 24. Global Nanopharmaceutical Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Nanopharmaceutical Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanopharmaceutical Drugs as of 2023)

Table 26. Global Key Manufacturers of Nanopharmaceutical Drugs, Manufacturing Base Distribution and Headquarters

Table 27. Global Key Manufacturers of Nanopharmaceutical Drugs, Product Offered and Application

Table 28. Global Key Manufacturers of Nanopharmaceutical Drugs, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Nanopharmaceutical Drugs Sales by Type (2019-2024) & (K MT)

Table 31. Global Nanopharmaceutical Drugs Sales by Type (2025-2030) & (K MT)

Table 32. Global Nanopharmaceutical Drugs Sales Share by Type (2019-2024)

Table 33. Global Nanopharmaceutical Drugs Sales Share by Type (2025-2030)

Table 34. Global Nanopharmaceutical Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 35. Global Nanopharmaceutical Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 36. Global Nanopharmaceutical Drugs Revenue Share by Type (2019-2024)

Table 37. Global Nanopharmaceutical Drugs Revenue Share by Type (2025-2030)

Table 38. Nanopharmaceutical Drugs Price by Type (2019-2024) & (USD/MT)

Table 39. Global Nanopharmaceutical Drugs Price Forecast by Type (2025-2030) & (USD/MT)

Table 40. Global Nanopharmaceutical Drugs Sales by Application (2019-2024) & (K MT)

Table 41. Global Nanopharmaceutical Drugs Sales by Application (2025-2030) & (K MT)

Table 42. Global Nanopharmaceutical Drugs Sales Share by Application (2019-2024)

Table 43. Global Nanopharmaceutical Drugs Sales Share by Application (2025-2030)

Table 44. Global Nanopharmaceutical Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 45. Global Nanopharmaceutical Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 46. Global Nanopharmaceutical Drugs Revenue Share by Application (2019-2024)

Table 47. Global Nanopharmaceutical Drugs Revenue Share by Application (2025-2030)

Table 48. Nanopharmaceutical Drugs Price by Application (2019-2024) & (USD/MT)

Table 49. Global Nanopharmaceutical Drugs Price Forecast by Application (2025-2030) & (USD/MT)

Table 50. US & Canada Nanopharmaceutical Drugs Sales by Type (2019-2024) & (K MT)

Table 51. US & Canada Nanopharmaceutical Drugs Sales by Type (2025-2030) & (K MT)

Table 52. US & Canada Nanopharmaceutical Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 53. US & Canada Nanopharmaceutical Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 54. US & Canada Nanopharmaceutical Drugs Sales by Application (2019-2024) & (K MT)

Table 55. US & Canada Nanopharmaceutical Drugs Sales by Application (2025-2030) & (K MT)

Table 56. US & Canada Nanopharmaceutical Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 57. US & Canada Nanopharmaceutical Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 58. US & Canada Nanopharmaceutical Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 59. US & Canada Nanopharmaceutical Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 60. US & Canada Nanopharmaceutical Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 61. US & Canada Nanopharmaceutical Drugs Sales by Country (2019-2024) & (K MT)

Table 62. US & Canada Nanopharmaceutical Drugs Sales by Country (2025-2030) & (K MT)

Table 63. Europe Nanopharmaceutical Drugs Sales by Type (2019-2024) & (K MT)

Table 64. Europe Nanopharmaceutical Drugs Sales by Type (2025-2030) & (K MT)

Table 65. Europe Nanopharmaceutical Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 66. Europe Nanopharmaceutical Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 67. Europe Nanopharmaceutical Drugs Sales by Application (2019-2024) & (K MT)

Table 68. Europe Nanopharmaceutical Drugs Sales by Application (2025-2030) & (K MT)

Table 69. Europe Nanopharmaceutical Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 70. Europe Nanopharmaceutical Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 71. Europe Nanopharmaceutical Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 72. Europe Nanopharmaceutical Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 73. Europe Nanopharmaceutical Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 74. Europe Nanopharmaceutical Drugs Sales by Country (2019-2024) & (K MT)

Table 75. Europe Nanopharmaceutical Drugs Sales by Country (2025-2030) & (K MT)

Table 76. China Nanopharmaceutical Drugs Sales by Type (2019-2024) & (K MT)

Table 77. China Nanopharmaceutical Drugs Sales by Type (2025-2030) & (K MT)

Table 78. China Nanopharmaceutical Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 79. China Nanopharmaceutical Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 80. China Nanopharmaceutical Drugs Sales by Application (2019-2024) & (K MT)

Table 81. China Nanopharmaceutical Drugs Sales by Application (2025-2030) & (K MT)

Table 82. China Nanopharmaceutical Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 83. China Nanopharmaceutical Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 84. Asia Nanopharmaceutical Drugs Sales by Type (2019-2024) & (K MT)

Table 85. Asia Nanopharmaceutical Drugs Sales by Type (2025-2030) & (K MT)

Table 86. Asia Nanopharmaceutical Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 87. Asia Nanopharmaceutical Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 88. Asia Nanopharmaceutical Drugs Sales by Application (2019-2024) & (K MT)

Table 89. Asia Nanopharmaceutical Drugs Sales by Application (2025-2030) & (K MT)

Table 90. Asia Nanopharmaceutical Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 91. Asia Nanopharmaceutical Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 92. Asia Nanopharmaceutical Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 93. Asia Nanopharmaceutical Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 94. Asia Nanopharmaceutical Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 95. Asia Nanopharmaceutical Drugs Sales by Region (2019-2024) & (K MT)

Table 96. Asia Nanopharmaceutical Drugs Sales by Region (2025-2030) & (K MT)

Table 97. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Type (2019-2024) & (K MT)

Table 98. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Type (2025-2030) & (K MT)

Table 99. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 100. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 101. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Application (2019-2024) & (K MT)

Table 102. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Application (2025-2030) & (K MT)

Table 103. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 106. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 107. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 108. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Country (2019-2024) & (K MT)

Table 109. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales by Country (2025-2030) & (K MT)

Table 110. Pfizer Company Information

Table 111. Pfizer Description and Major Businesses

Table 112. Pfizer Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 113. Pfizer Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Pfizer Recent Developments

Table 115. Merck Company Information

Table 116. Merck Description and Major Businesses

Table 117. Merck Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 118. Merck Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Merck Recent Developments

Table 120. AstraZeneca Company Information

Table 121. AstraZeneca Description and Major Businesses

Table 122. AstraZeneca Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 123. AstraZeneca Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. AstraZeneca Recent Developments

Table 125. Gilead Sciences Company Information

Table 126. Gilead Sciences Description and Major Businesses

Table 127. Gilead Sciences Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 128. Gilead Sciences Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Gilead Sciences Recent Developments

Table 130. Abbvie Company Information

Table 131. Abbvie Description and Major Businesses

Table 132. Abbvie Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 133. Abbvie Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Abbvie Recent Developments

Table 135. Amgen Company Information

Table 136. Amgen Description and Major Businesses

Table 137. Amgen Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 138. Amgen Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Amgen Recent Developments

Table 140. Roche Company Information

Table 141. Roche Description and Major Businesses

Table 142. Roche Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 143. Roche Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Roche Recent Developments

Table 145. Novartis Company Information

Table 146. Novartis Description and Major Businesses

Table 147. Novartis Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 148. Novartis Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Novartis Recent Developments

Table 150. Sanofi Company Information

Table 151. Sanofi Description and Major Businesses

Table 152. Sanofi Nanopharmaceutical Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 153. Sanofi Nanopharmaceutical Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Sanofi Recent Developments

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Nanopharmaceutical Drugs Distributors List

Table 158. Nanopharmaceutical Drugs Customers List

Table 159. Nanopharmaceutical Drugs Market Trends

Table 160. Nanopharmaceutical Drugs Market Drivers

Table 161. Nanopharmaceutical Drugs Market Challenges

Table 162. Nanopharmaceutical Drugs Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Nanopharmaceutical Drugs Product Picture

Figure 2. Global Nanopharmaceutical Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Nanopharmaceutical Drugs Market Share by Type in 2023 & 2030

Figure 4. Liposomes Product Picture

Figure 5. Polymer Product Picture

Figure 6. Nanocrystals Product Picture

Figure 7. Protein Product Picture

Figure 8. Others Product Picture

Figure 9. Global Nanopharmaceutical Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Nanopharmaceutical Drugs Market Share by Application in 2023 & 2030

Figure 11. Oncology

Figure 12. Neurology

Figure 13. Immunology

Figure 14. Anti-Infective

Figure 15. Cardiovascular

Figure 16. Others

Figure 17. Nanopharmaceutical Drugs Report Years Considered

Figure 18. Global Nanopharmaceutical Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Nanopharmaceutical Drugs Revenue 2019-2030 (US$ Million)

Figure 20. Global Nanopharmaceutical Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 21. Global Nanopharmaceutical Drugs Revenue Market Share by Region (2019-2030)

Figure 22. Global Nanopharmaceutical Drugs Sales 2019-2030 ((K MT)

Figure 23. Global Nanopharmaceutical Drugs Sales Market Share by Region (2019-2030)

Figure 24. US & Canada Nanopharmaceutical Drugs Sales YoY (2019-2030) & (K MT)

Figure 25. US & Canada Nanopharmaceutical Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Europe Nanopharmaceutical Drugs Sales YoY (2019-2030) & (K MT)

Figure 27. Europe Nanopharmaceutical Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 28. China Nanopharmaceutical Drugs Sales YoY (2019-2030) & (K MT)

Figure 29. China Nanopharmaceutical Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Asia (excluding China) Nanopharmaceutical Drugs Sales YoY (2019-2030) & (K MT)

Figure 31. Asia (excluding China) Nanopharmaceutical Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 32. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales YoY (2019-2030) & (K MT)

Figure 33. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 34. The Nanopharmaceutical Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 35. The Top 5 and 10 Largest Manufacturers of Nanopharmaceutical Drugs in the World: Market Share by Nanopharmaceutical Drugs Revenue in 2023

Figure 36. Global Nanopharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 37. Global Nanopharmaceutical Drugs Sales Market Share by Type (2019-2030)

Figure 38. Global Nanopharmaceutical Drugs Revenue Market Share by Type (2019-2030)

Figure 39. Global Nanopharmaceutical Drugs Sales Market Share by Application (2019-2030)

Figure 40. Global Nanopharmaceutical Drugs Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada Nanopharmaceutical Drugs Sales Market Share by Type (2019-2030)

Figure 42. US & Canada Nanopharmaceutical Drugs Revenue Market Share by Type (2019-2030)

Figure 43. US & Canada Nanopharmaceutical Drugs Sales Market Share by Application (2019-2030)

Figure 44. US & Canada Nanopharmaceutical Drugs Revenue Market Share by Application (2019-2030)

Figure 45. US & Canada Nanopharmaceutical Drugs Revenue Share by Country (2019-2030)

Figure 46. US & Canada Nanopharmaceutical Drugs Sales Share by Country (2019-2030)

Figure 47. U.S. Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 48. Canada Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 49. Europe Nanopharmaceutical Drugs Sales Market Share by Type (2019-2030)

Figure 50. Europe Nanopharmaceutical Drugs Revenue Market Share by Type (2019-2030)

Figure 51. Europe Nanopharmaceutical Drugs Sales Market Share by Application (2019-2030)

Figure 52. Europe Nanopharmaceutical Drugs Revenue Market Share by Application (2019-2030)

Figure 53. Europe Nanopharmaceutical Drugs Revenue Share by Country (2019-2030)

Figure 54. Europe Nanopharmaceutical Drugs Sales Share by Country (2019-2030)

Figure 55. Germany Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 56. France Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 57. U.K. Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 58. Italy Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 59. Russia Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 60. China Nanopharmaceutical Drugs Sales Market Share by Type (2019-2030)

Figure 61. China Nanopharmaceutical Drugs Revenue Market Share by Type (2019-2030)

Figure 62. China Nanopharmaceutical Drugs Sales Market Share by Application (2019-2030)

Figure 63. China Nanopharmaceutical Drugs Revenue Market Share by Application (2019-2030)

Figure 64. Asia Nanopharmaceutical Drugs Sales Market Share by Type (2019-2030)

Figure 65. Asia Nanopharmaceutical Drugs Revenue Market Share by Type (2019-2030)

Figure 66. Asia Nanopharmaceutical Drugs Sales Market Share by Application (2019-2030)

Figure 67. Asia Nanopharmaceutical Drugs Revenue Market Share by Application (2019-2030)

Figure 68. Asia Nanopharmaceutical Drugs Revenue Share by Region (2019-2030)

Figure 69. Asia Nanopharmaceutical Drugs Sales Share by Region (2019-2030)

Figure 70. Japan Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 71. South Korea Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 72. China Taiwan Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 73. Southeast Asia Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 74. India Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 75. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America Nanopharmaceutical Drugs Revenue Share by Country (2019-2030)

Figure 80. Middle East, Africa and Latin America Nanopharmaceutical Drugs Sales Share by Country (2019-2030)

Figure 81. Brazil Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 82. Mexico Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 83. Turkey Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 84. Israel Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 85. GCC Countries Nanopharmaceutical Drugs Revenue (2019-2030) & (US$ Million)

Figure 86. Nanopharmaceutical Drugs Value Chain

Figure 87. Nanopharmaceutical Drugs Production Process

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions